In addition, women inheriting pathogenic BRCA2 mutation/s have a considerably increased risk to develop ovarian cancer (11-17% risk versus 1.2% in the general population) (https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet#r4) (2). This evidence concerns the gene BRCA2 and cancer.